Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cebelia
- Development stage
- Unknown
- Lead developer
- Laboratoires d'Anjou
- Modality
- Small Molecules, Peptides
- Administration
- Topical
01
Overview
Cebelia is a French dermo-aesthetic skincare brand developed by Laboratoires d'Anjou in collaboration with French research institutions such as CNRS and INSERM. The product line is specifically designed to support skin repair and maintenance before and after medical aesthetic procedures, including laser treatments, chemical peels, and injections. The brand features patented active ingredients such as Pekaline (a melanogenesis inhibitor) and the LCE (Laminin, Cytokine, Elastin) complex. Pekaline targets the protein kinase A (PKA) pathway to inhibit melanin production and melanosome maturation, making it effective for hyperpigmentation. The LCE complex promotes epidermal regeneration by stimulating Laminin 5, which is essential for cell adhesion and skin barrier repair. In China, Cebelia is distributed and commercialized through a partnership with Profex.
- Brand names
- CebeliaCebelia Extreme CareCebelia Reinforced DepigmentingCebelia LCE RegardCebelia Comfort CreamCebelia LCE BalmCebelia Anti-Hair Loss
- Other names
- Cebelia-Profex
02
Targets
PKA (Cyclic amp-dependent protein kinase)
Beyond the preview
Go deeper on Cebelia.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cebelia.